http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102291748-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-316 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-125 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-125 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate | 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102291748-B1 |
| titleOfInvention | A pharmaceutical composition comprising ginsenoside Rg2, Rg4, Rg6, Rh1 and Rh4 for preventing or treating muscular disease |
| abstract | The present invention relates to a composition for preventing or treating a muscle disease comprising at least one selected from ginsenoside Rg2, Rg4, Rg6, Rh1 and Rh4 as an active ingredient. When the ginsenoside is treated in cells induced by muscle atrophy or in mice induced by aging, the effect of promoting differentiation into the root canal and the regeneration of muscle tissue are excellent, so that muscle diseases, particularly muscle diseases caused by decreased muscle function, muscle wasting, or muscle degeneration It can be usefully used to treat diseases. |
| priorityDate | 2019-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 84.